| Year |
Citation |
Score |
| 2020 |
Rogers CJ, Lukaszewicz AI, Yamada-Hanff J, Micewicz ED, Ratikan JA, Starbird MA, Miller TA, Nguyen C, Lee JT, Olafsen T, Iwamoto KS, McBride WH, Schaue D, Menon N. Identification of miRNA signatures associated with radiation-induced late lung injury in mice. Plos One. 15: e0232411. PMID 32392259 DOI: 10.1371/Journal.Pone.0232411 |
0.324 |
|
| 2019 |
Wang C, Kishan AU, Yu JB, Raldow A, King CR, Iwamoto KS, Chu FI, Steinberg ML, Kupelian PA. Association between Long-Term Second Malignancy Risk and Radiation: A Comprehensive Analysis of the Entire Surveillance, Epidemiology, and End Results Database (1973-2014). Advances in Radiation Oncology. 4: 738-747. PMID 31673667 DOI: 10.1016/J.Adro.2019.05.003 |
0.362 |
|
| 2019 |
Micewicz ED, Iwamoto KS, Ratikan JA, Nguyen C, Xie MW, Cheng G, Boxx GM, Deriu E, Damoiseaux RD, Whitelegge JP, Ruchala PP, Avetisyan R, Jung ME, Lawson G, Nemeth E, et al. The Aftermath of Surviving Acute Radiation Hematopoietic Syndrome and its Mitigation. Radiation Research. PMID 30730284 DOI: 10.1667/Rr15231.1 |
0.417 |
|
| 2017 |
Purbey PK, Scumpia PO, Kim PJ, Tong AJ, Iwamoto KS, McBride WH, Smale ST. Defined Sensing Mechanisms and Signaling Pathways Contribute to the Global Inflammatory Gene Expression Output Elicited by Ionizing Radiation. Immunity. 47: 421-434.e3. PMID 28930658 DOI: 10.1016/J.Immuni.2017.08.017 |
0.348 |
|
| 2017 |
Micewicz ED, Kim K, Iwamoto KS, Ratikan JA, Cheng G, Boxx GM, Damoiseaux RD, Whitelegge JP, Ruchala P, Nguyen C, Purbey P, Loo J, Deng G, Jung ME, Sayre JW, et al. 4-(Nitrophenylsulfonyl)piperazines mitigate radiation damage to multiple tissues. Plos One. 12: e0181577. PMID 28732024 DOI: 10.1371/Journal.Pone.0181577 |
0.419 |
|
| 2016 |
Valdes G, Lee C, Tenn S, Lee P, Robinson C, Iwamoto K, Low D, Lamb JM. The relative accuracy of 4D dose accumulation for lung radiotherapy using rigid dose projection versus dose recalculation on every breathing phase. Medical Physics. PMID 28019649 DOI: 10.1002/Mp.12069 |
0.338 |
|
| 2015 |
Elgart SR, Bostani M, Mok KC, Adibi A, Ruehm S, Enzmann D, McNitt-Gray M, Iwamoto KS. Investigation of DNA Damage Dose-Response Kinetics after Ionizing Radiation Schemes Similar to CT Protocols. Radiation Research. 183: 701-7. PMID 25950819 DOI: 10.1667/Rr13752.1 |
0.406 |
|
| 2015 |
Valdes G, Robinson C, Lee P, Morel D, Low D, Iwamoto KS, Lamb JM. Tumor control probability and the utility of 4D vs 3D dose calculations for stereotactic body radiotherapy for lung cancer. Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists. 40: 64-9. PMID 25542785 DOI: 10.1016/J.Meddos.2014.10.002 |
0.346 |
|
| 2014 |
Takahashi M, Valdes G, Hiraoka K, Inagaki A, Kamijima S, Micewicz E, Gruber HE, Robbins JM, Jolly DJ, McBride WH, Iwamoto KS, Kasahara N. Radiosensitization of gliomas by intracellular generation of 5-fluorouracil potentiates prodrug activator gene therapy with a retroviral replicating vector. Cancer Gene Therapy. 21: 405-10. PMID 25301172 DOI: 10.1038/Cgt.2014.38 |
0.35 |
|
| 2014 |
Elgart S, Adibi A, Bostani M, Ruehm S, Enzmann D, McNitt-Gray M, Iwamoto K. TH‐C‐18A‐09: Exam and Patient Parameters Affecting the DNA Damage Response Following CT Studies Medical Physics. 41: 558-559. DOI: 10.1118/1.4889633 |
0.344 |
|
| 2014 |
Takahashi M, Valdes G, Inagaki A, Kamijima S, Hiraoka K, Micewicz E, McBride WH, Iwamoto KS, Hermann K, Collins S, Tam Q, Gruber HE, Robbins JM, Jolly DJ, Kasahara N. ET-60 * ENHANCED THERAPEUTIC EFFICACY OF PRODRUG ACTIVATOR GENE THERAPY WITH A NON-LYTIC RETROVIRAL REPLICATING VECTOR (TOCA 511) COMBINED WITH RADIATION THERAPY IN EXPERIMENTAL GLIOMA Neuro-Oncology. 16: v92-v92. DOI: 10.1093/Neuonc/Nou255.57 |
0.392 |
|
| 2013 |
Valdes G, Iwamoto KS. Re-evaluation of cellular radiosensitization by 5-fluorouracil: high-dose, pulsed administration is effective and preferable to conventional low-dose, chronic administration. International Journal of Radiation Biology. 89: 851-62. PMID 23607451 DOI: 10.3109/09553002.2013.797620 |
0.39 |
|
| 2013 |
Elgart S, Adibi A, Khatonabadi M, Ruehm S, Enzmann D, McNitt-Gray M, Iwamoto K. MO-D-134-09: Assessing DNA Damage Repair From CT Studies in Whole Blood Medical Physics. 40: 403-404. DOI: 10.1118/1.4815267 |
0.319 |
|
| 2013 |
Valdes G, Lamb J, Low D, Lee P, Iwamoto K. SU‐E‐T‐414: 4D Vs 3D Dose Calculations for Non‐Small‐Lung‐Cancer: A Comparison Using Tumor Control Probability (TCP) Medical Physics. 40: 300-300. DOI: 10.1118/1.4814848 |
0.352 |
|
| 2012 |
Schaue D, Ratikan JA, Iwamoto KS. Cellular autofluorescence following ionizing radiation. Plos One. 7: e32062. PMID 22384140 DOI: 10.1371/Journal.Pone.0032062 |
0.408 |
|
| 2012 |
Schaue D, Ratikan JA, Iwamoto KS, McBride WH. Maximizing tumor immunity with fractionated radiation. International Journal of Radiation Oncology, Biology, Physics. 83: 1306-10. PMID 22208977 DOI: 10.1016/J.Ijrobp.2011.09.049 |
0.431 |
|
| 2012 |
Elgart S, Khatonabadi M, McNitt-Gray M, Ruehm S, Adibi A, Iwamoto K. WE-A-218-02: Assessing the Repair of DNA Damage from Multi-Pass CT Protocols Medical Physics. 39: 3938-3938. DOI: 10.1118/1.4736071 |
0.399 |
|
| 2011 |
Kachikwu EL, Iwamoto KS, Liao YP, DeMarco JJ, Agazaryan N, Economou JS, McBride WH, Schaue D. Radiation enhances regulatory T cell representation. International Journal of Radiation Oncology, Biology, Physics. 81: 1128-35. PMID 21093169 DOI: 10.1016/J.Ijrobp.2010.09.034 |
0.377 |
|
| 2011 |
Saxon S, McNitt‐Gray M, Ruehm S, Iwamoto K. SU‐E‐T‐21: Repair of DNA Damage from Ionizing Radiation in the Range of Doses Experienced in CT Studies Medical Physics. 38: 3490-3490. DOI: 10.1118/1.3611971 |
0.416 |
|
| 2010 |
DeMarco J, Saxon S, Fahimian B, Iwamoto K. SU‐GG‐T‐492: Determining RBE Values for a New Miniaturized X‐Ray Source Medical Physics. 37: 3300-3300. DOI: 10.1118/1.3468890 |
0.366 |
|
| 2009 |
Kim K, Pollard JM, Norris AJ, McDonald JT, Sun Y, Micewicz E, Pettijohn K, Damoiseaux R, Iwamoto KS, Sayre JW, Price BD, Gatti RA, McBride WH. High-throughput screening identifies two classes of antibiotics as radioprotectors: tetracyclines and fluoroquinolones. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 7238-45. PMID 19920105 DOI: 10.1158/1078-0432.Ccr-09-1964 |
0.359 |
|
| 2009 |
Liao YP, Wang CC, Schaue D, Iwamoto KS, McBride WH. Local irradiation of murine melanoma affects the development of tumour-specific immunity. Immunology. 128: e797-804. PMID 19740341 DOI: 10.1111/J.1365-2567.2009.03084.X |
0.364 |
|
| 2009 |
Brush JM, Kim K, Sayre JW, McBride WH, Iwamoto KS. Imaging of radiation effects on cellular 26S proteasome function in situ. International Journal of Radiation Biology. 85: 483-94. PMID 19401903 DOI: 10.1080/09553000902883794 |
0.394 |
|
| 2009 |
DeMarco J, Fahimian B, Iwamoto K, Holt R. SU‐FF‐T‐07: Treatment Planning Considerations and the Effect of Tissue Heterogeneities On the Absorbed Dose Distribution From the Xoft Axxent 50 KVp Electronic Brachytherapy Source Medical Physics. 36: 2520-2520. DOI: 10.1118/1.3181478 |
0.321 |
|
| 2008 |
Hafer K, Iwamoto KS, Schiestl RH. Refinement of the dichlorofluorescein assay for flow cytometric measurement of reactive oxygen species in irradiated and bystander cell populations. Radiation Research. 169: 460-8. PMID 18363435 DOI: 10.1667/Rr1212.1 |
0.395 |
|
| 2008 |
Kim K, Brush JM, Watson PA, Cacalano NA, Iwamoto KS, McBride WH. Epidermal growth factor receptor vIII expression in U87 glioblastoma cells alters their proteasome composition, function, and response to irradiation. Molecular Cancer Research : McR. 6: 426-34. PMID 18337449 DOI: 10.1158/1541-7786.Mcr-07-0313 |
0.32 |
|
| 2008 |
Fahimian B, DeMarco J, Holzscheiter M, Keyes R, Bassler N, Iwamoto K, Zankl M. MO-E-AUD B-02: Antiproton Therapy: Monte Carlo Simulations of Normal Tissue Equivalent Dose From Annihilation Neutrons Medical Physics. 35: 2874-2874. DOI: 10.1118/1.2962384 |
0.369 |
|
| 2007 |
Hafer K, Iwamoto KS, Iwamoto KK, Scuric Z, Schiestl RH. Adaptive response to gamma radiation in mammalian cells proficient and deficient in components of nucleotide excision repair. Radiation Research. 168: 168-74. PMID 17638404 DOI: 10.1667/Rr0717.1 |
0.344 |
|
| 2007 |
Iwamoto KS, Barber CL. Radiation-induced posttranscriptional control of M6P/IGF2r expression in breast cancer cell lines. Molecular Carcinogenesis. 46: 497-502. PMID 17295243 DOI: 10.1002/Mc.20303 |
0.331 |
|
| 2006 |
Iwamoto KS, Yano S, Barber CL, MacPhee DG, Tokuoka S. A dose-dependent decrease in the fraction of cases harboring M6P/IGF2R mutations in hepatocellular carcinomas from the atomic bomb survivors. Radiation Research. 166: 870-6. PMID 17149973 DOI: 10.1667/Rr0585.1 |
0.354 |
|
| 2006 |
Wang CC, Liao YP, Mischel PS, Iwamoto KS, Cacalano NA, McBride WH. HDJ-2 as a target for radiosensitization of glioblastoma multiforme cells by the farnesyltransferase inhibitor R115777 and the role of the p53/p21 pathway. Cancer Research. 66: 6756-62. PMID 16818651 DOI: 10.1158/0008-5472.Can-06-0185 |
0.323 |
|
| 2006 |
Mizuno T, Tokuoka S, Kishikawa M, Nakashima E, Mabuchi K, Iwamoto KS. Molecular basis of basal cell carcinogenesis in the atomic-bomb survivor population: p53 and PTCH gene alterations. Carcinogenesis. 27: 2286-94. PMID 16777989 DOI: 10.1093/Carcin/Bgl107 |
0.361 |
|
| 2006 |
Hafer K, Scuric Z, Iwamoto KS, Schiestl RH. Point-source irradiation with eccentric rotation causes inhomogeneous dose distribution. Radiation Research. 165: 616-20. PMID 16669744 DOI: 10.1667/Rr3524.1 |
0.365 |
|
| 2005 |
Pervan M, Iwamoto KS, McBride WH. Proteasome structures affected by ionizing radiation. Molecular Cancer Research : McR. 3: 381-90. PMID 16046549 DOI: 10.1158/1541-7786.Mcr-05-0032 |
0.422 |
|
| 2004 |
Liao YP, Wang CC, Butterfield LH, Economou JS, Ribas A, Meng WS, Iwamoto KS, McBride WH. Ionizing radiation affects human MART-1 melanoma antigen processing and presentation by dendritic cells. Journal of Immunology (Baltimore, Md. : 1950). 173: 2462-9. PMID 15294960 DOI: 10.4049/Jimmunol.173.4.2462 |
0.344 |
|
| 2004 |
McBride WH, Chiang CS, Olson JL, Wang CC, Hong JH, Pajonk F, Dougherty GJ, Iwamoto KS, Pervan M, Liao YP. A sense of danger from radiation. Radiation Research. 162: 1-19. PMID 15222781 DOI: 10.1667/Rr3196 |
0.384 |
|
| 2003 |
McBride WH, Iwamoto KS, Syljuasen R, Pervan M, Pajonk F. The role of the ubiquitin/proteasome system in cellular responses to radiation. Oncogene. 22: 5755-73. PMID 12947384 DOI: 10.1038/Sj.Onc.1206676 |
0.406 |
|
| 2003 |
Iwamoto KS. Tracking the errant cell after the atomic bombings: what went wrong? Health Physics. 85: 81-3. PMID 12852474 DOI: 10.1097/00004032-200307000-00014 |
0.41 |
|
| 2002 |
Chen WC, McBride WH, Iwamoto KS, Barber CL, Wang CC, Oh YT, Liao YP, Hong JH, de Vellis J, Shau H. Induction of radioprotective peroxiredoxin-I by ionizing irradiation. Journal of Neuroscience Research. 70: 794-8. PMID 12444601 DOI: 10.1002/Jnr.10435 |
0.427 |
|
| 2000 |
Mizuno T, Iwamoto KS, Kyoizumi S, Nagamura H, Shinohara T, Koyama K, Seyama T, Hamatani K. Preferential induction of RET/PTC1 rearrangement by X-ray irradiation. Oncogene. 19: 438-443. PMID 10656692 DOI: 10.1038/Sj.Onc.1203343 |
0.383 |
|
| 1999 |
Iwamoto KS, Fujii S, Kurata A, Suzuki M, Hayashi T, Ohtsuki Y, Okada Y, Narita M, Takahashi M, Hosobe S, Doishita K, Manabe T, Hata S, Murakami I, Hata S, et al. p53 mutations in tumor and non-tumor tissues of thorotrast recipients: a model for cellular selection during radiation carcinogenesis in the liver. Carcinogenesis. 20: 1283-1291. PMID 10383902 DOI: 10.1093/Carcin/20.7.1283 |
0.387 |
|
| 1998 |
Iwamoto KS, Mizuno T, Kurata A, Masuzawa M, Mori T, Seyama T. Multiple, unique, and common p53 mutations in a thorotrast recipient with four primary cancers Human Pathology. 29: 412-416. PMID 9563795 DOI: 10.1016/S0046-8177(98)90126-5 |
0.303 |
|
| 1997 |
Mizuno T, Kyoizumi S, Suzuki T, Iwamoto KS, Seyama T. Continued expression of a tissue specific activated oncogene in the early steps of radiation-induced human thyroid carcinogenesis Oncogene. 15: 1455-1460. PMID 9333021 DOI: 10.1038/Sj.Onc.1201313 |
0.351 |
|
| 1997 |
Norman A, Ingram M, Skillen RG, Freshwater DB, Iwamoto KS, Solberg T. X-ray phototherapy for canine brain masses. Radiation Oncology Investigations. 5: 8-14. PMID 9303051 DOI: 10.1002/(Sici)1520-6823(1997)5:1<8::Aid-Roi2>3.0.Co;2-1 |
0.362 |
|
| 1994 |
Iwamoto KS, Hirai Y, Umeki S, Kusunoki Y, Kyoizumi S, Kodama T, Ohama K, Nakamura N, Akiyama M. A Positive Correlation between T-Cell-receptor Mutant Frequencies and Dicentric Chromosome Frequencies in Lymphocytes from Radiotherapy Patients Journal of Radiation Research. 35: 92-103. PMID 7965994 DOI: 10.1269/Jrr.35.92 |
0.343 |
|
| 1994 |
Iwamoto KS, McBride WH. Production of 13-Hydroxyoctadecadienoic Acid and Tumor Necrosis Factor-α by Murine Peritoneal Macrophages in Response to Irradiation Radiation Research. 139: 103. DOI: 10.2307/3578739 |
0.329 |
|
| 1992 |
Solberg TD, Iwamoto KS, Norman A. Calculation of radiation dose enhancement factors for dose enhancement therapy of brain tumours. Physics in Medicine and Biology. 37: 439-43. PMID 1553392 DOI: 10.1088/0031-9155/37/2/010 |
0.389 |
|
| 1991 |
Norman A, Iwamoto KS, Cochran ST. Iodinated contrast agents for brain tumor localization and radiation dose enhancement. Investigative Radiology. 26: S120-1; discussion S. PMID 1808106 DOI: 10.1097/00004424-199111001-00040 |
0.396 |
|
| 1990 |
Iwamoto KS, Norman A, Kagan AR, Wollin M, Olch A, Bellotti J, Ingram M, Skillen RG. The CT scanner as a therapy machine Radiotherapy and Oncology. 19: 337-343. PMID 2126635 DOI: 10.1016/0167-8140(90)90034-T |
0.3 |
|
| 1987 |
Iwamoto KS, Cochran ST, Winter J, Holburt E, Higashida RT, Norman A. Radiation dose enhancement therapy with iodine in rabbit VX-2 brain tumors. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 8: 161-70. PMID 3562895 DOI: 10.1016/S0167-8140(87)80170-6 |
0.423 |
|
| Show low-probability matches. |